1. Detecting functional changes with [18F]FAZA in a renal cell carcinoma mouse model following sunitinib therapy
   David W Chapman et al, 2014, EJNMMI Research CrossRef
2. Synergistic growth inhibition by sorafenib and cisplatin in human osteosarcoma cells
   QU YANG et al, 2015, Oncology Reports CrossRef
3. Choosing The Right Animal Model for Renal Cancer Research
   Paweł Sobczuk et al, 2020, Translational Oncology CrossRef
4. Radiomics Analysis on FLT-PET/MRI for Characterization of Early Treatment Response in Renal Cell Carcinoma: A Proof-of-Concept Study
   Jacob Antunes et al, 2016, Translational Oncology CrossRef
5. Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo
   HONG ZHANG et al, 2014, Oncology Reports CrossRef
6. A rapid ex vivo tissue model for optimising drug detection and ionisation in MALDI imaging studies
   K. Huber et al, 2014, Histochemistry and Cell Biology CrossRef
7. Treatment evaluation and prognosis prediction using radiomics in clinical practice
   Jie Tian et al, 2021, Radiomics and Its Clinical Application CrossRef
8. Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft
   Naoyuki Ukon et al, 2016, EJNMMI Research CrossRef
9. Novel Approach of MALDI Drug Imaging, Immunohistochemistry, and Digital Image Analysis for Drug Distribution Studies in Tissues
   Katharina Huber et al, 2014, Analytical Chemistry CrossRef